Skip to main content
. 2022 Dec 2;13:1054741. doi: 10.3389/fendo.2022.1054741

Table 5.

Sensitivity analysis of the association of TyG index variability with incident diabetes.

Sensitivity analysis 1 Sensitivity analysis 2 Sensitivity analysis 3 Sensitivity analysis 4
Q1 1.00 1.00 1.00 1.00
Q2 1.04 (0.95,1.14) 1.02 (0.93,1.12) 1.11 (0.98,1.26) 1.03 (0.94,1.13)
Q3 1.13 (1.03,1.24) 1.13 (1.03,1.24) 1.17 (1.03,1.33) 1.13 (1.03,1.23)
Q4 1.18 (1.08,1.29) 1.19 (1.06,1.28) 1.42 (1.25,1.62) 1.22 (1.12,1.34)
P for Trend <0.0001 0.0002 <0.0001 <0.0001

Adjusted for age (continuous variable, years), sex (categorical variable, men or women), LDL-C (as a continuous variable), HDL-C (as a continuous variable), hs-CRP (as a continuous variable), BMI (as a continuous variable), smoking status (as a categorical variable, yes or no), alcohol consumption status (as a categorical variable, yes or no), physical exercise habits (as a categorical variable, yes or no), educational level (as a categorical variable, high school or above vs. below high school level), hypertension (as a categorical variable, yes or no), the use of lipid-lowering drugs (as a categorical variable, yes or no, except sensitivity analysis 2), and TyG index (continuous variable) in baseline.

Sensitivity analysis 1: the exclusion of participants in whom diabetes developed within the first year of follow-up.

Sensitivity analysis 2: the exclusion of participants who were taking lipid-lowering or antihypertensive medication.

Sensitivity analysis 3: the exclusion of participants with TG ≥ 2.3 mmol/L in baseline.

Sensitivity analysis 4: adjusting for the baseline TG and FBG and without the inclusion of the baseline TyG-index.